Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Running

SMART Self-Monitoring of Prostate cancer by Automated hybrid Recognition of Exosomal miRNA: toward personalized analytical Tool

Coordinator
Universita Degli Studi Di Napoli Federico Ii, Italy
Runs
1 April 2024 to 30 April 2026
Status
Running
EU funding
€173k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101110684

What the project is doing

In the project's own words, from its summary on CORDIS.

Tumor-derived circulating exosomes are a suitable, readily accessible reservoir of cancer biomarkers for disease process analysis. The microRNAs (miRNAs) inside the exosomes provide information about the mechanisms of change in cancer of affected individuals. Quantitative determination of miRNAs in the exosome, a clinical area of unmet need, is tempting but challenging. The main objectives of the proposal are to develop a non-invasive, affordable, user-friendly, and deliverable platform that can measure mutant miRNA-107 in prostate cancer (PCa)-associated exosomes with unmatched accuracy, combining a hybrid oligonucleotides (ONs)-nanomaterials integrated composite system with an E-μPAD.

The proposed platform offers ""Self-Monitoring of Prostate Cancer by Automated hybrid Recognition of Exosomal miRNA: towards personalized analytical Tool"" named "" SMART"". SMART provides a universal technology for non-invasive PCa diagnosis and quantitative tracking of miRNA levels in cancer-derived exosomes in a very simple and effortless manner in biofluids such as serum and urine. The novelty of the proposed interdisciplinary project work will evolve into the next generation of intelligent point-of-care (POC) tools for precision medicine.

This proposal will contribute to the sustainability of the healthcare system by enabling patients to stratify and/or predict disease, thereby improving clinical decision making. This MSCA PF will be carried out at the University of Naples, Italy, will provide the researcher with advanced technical training in exosome isolation, PCR and DNA sequencing, molecular biology, microfluidics, pathology, nanomaterials synthesis, analytical techniques, proposal and manuscript preparation, and academic supervision in research management.

The proposed multidisciplinary collaboration in the SMART project has resulted in a new generation of smart medical devices with functions comparable to existing highly specialized hospital devices.""

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di Napoli Federico IiNapoliItalyCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI